RSS   Newsletter   Contact   Advertise with us

Forward Pharma appoints Claus Bo Svendsen as CEO

Staff Writer | Copenhagen, Denmark | March 2, 2017
Claus Bo SvendsenMarch 2, 2017, Copenhagen, Denmark - Forward Pharma, a biopharmaceutical company, announced that it has appointed Claus Bo Svendsen as chief executive officer.
Dr. Svendsen previously held the position of Executive Vice President at the Company.

Dr. Svendsen joined the Company in 2015, prior to which he held positions of increasing seniority in the Danish pharmaceutical company, Novo Nordisk A/S, with his last role being Global Medical Director.

Previously, Dr. Svendsen worked in biotech venture capital and has a clinical background in internal medicine.

Dr. Svendsen graduated as a Medical Doctor from University of Copenhagen in 2003, and additionally completed a Ph.D. in sarcoidosis pathobiology in 2009.